Gilead Sciences, Inc.
GILD
$96.99
-$1.17-1.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.92% | 0.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.92% | 0.32% | |||
| Cost of Revenue | -2.59% | 0.44% | |||
| Gross Profit | -14.38% | 0.28% | |||
| SG&A Expenses | -34.34% | 31.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.05% | 15.69% | |||
| Operating Income | 2.52% | -20.94% | |||
| Income Before Tax | -23.94% | 126.78% | |||
| Income Tax Expenses | -13.25% | 229.63% | |||
| Earnings from Continuing Operations | -26.25% | 42.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.25% | 42.30% | |||
| EBIT | 2.52% | -20.94% | |||
| EBITDA | 2.07% | -17.12% | |||
| EPS Basic | -26.13% | 42.19% | |||
| Normalized Basic EPS | 2.64% | -21.23% | |||
| EPS Diluted | -26.18% | 40.89% | |||
| Normalized Diluted EPS | 2.47% | -21.49% | |||
| Average Basic Shares Outstanding | -0.16% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.40% | |||
| Dividend Per Share | 2.60% | 0.00% | |||
| Payout Ratio | 0.41% | -0.30% | |||